Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

about

Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma

P2860

Q58694947-331455A7-8C25-43E7-9BE0-3B4143DE973A

P2860

Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

Item

http://www.wikidata.org/entity/Q49386829

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current Methods to Define Meta ...... mography: Which One is Better?

@en

Current Methods to Define Meta ...... mography: Which One is Better?

@nl

type

Item

label

Current Methods to Define Meta ...... mography: Which One is Better?

@en

Current Methods to Define Meta ...... mography: Which One is Better?

@nl

prefLabel

Current Methods to Define Meta ...... mography: Which One is Better?

@en

Current Methods to Define Meta ...... mography: Which One is Better?

@nl

P1476

Current Methods to Define Meta ...... mography: Which One is Better?

@en

P2093

Hyung-Jun Im

http://www.w3.org/2001/XMLSchema#string

Meiyappan Solaiyappan

http://www.w3.org/2001/XMLSchema#string

Steve Y Cho

http://www.w3.org/2001/XMLSchema#string

Tyler Bradshaw

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of volume-based PET parameters in cancer patients.

Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.

18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response

Artificial Neural Network-Based System for PET Volume Segmentation.

Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.

Imaging pulmonary inducible nitric oxide synthase expression with PET.

Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.

Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.

What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom.

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.

P2888

s13139-017-0493-6

P304

5-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13139-017-0493-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091845760

http://www.w3.org/2001/XMLSchema#string

P698

29391907

http://www.w3.org/2001/XMLSchema#string

P932

5777960

http://www.w3.org/2001/XMLSchema#string

Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

about

P2860

P2860

Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932